| http://www.w3.org/ns/prov#value | - effect on plasma lipid alpha-blockers, the Renin Angiotensin Aldosterone System (RAAS) blocker or the calcium channel blocker may be the preferred initial therapy in patients with underlying hyperlipidemia. [46] Lipitension and Coronary Artery Disease Lipitension, as a combination, is an important risk factor for the progression of atherosclerosis in CAD patients.
|
